COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 1447: Articles 14461-14470  | Next

Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection
Schultz, D., Johnson, R., Ayyanathan, K., Miller, J., Whig, K., Kamalia, B., Dittmar, M., Weston, S., Hammond, H., Dillen, C., Castellana, L., Lee, J. S., Li, M., Lee, E. M., Constant, S., Ferrer, M., Thaiss, C., Frieman, M., Cherry, S.
10.1101/2021.06.24.449811 — Posted: 2021-06-24
Integrative COVID-19 Biological Network Inference with Probabilistic Core Decomposition
Guo, Y., Esfahani, F., Shao, X., Srinivasan, V., Thomo, A., Xing, L., Zhang, X.
10.1101/2021.06.23.449535 — Posted: 2021-06-24
E484K and N501Y SARS-CoV 2 Spike Mutants Increase ACE2 Recognition but Reduce Affinity for Neutralizing Antibody
Chakraborty, S.
10.1101/2021.06.23.449627 — Posted: 2021-06-24
Structure, activity and inhibition of human TMPRSS2, a protease implicated in SARS-CoV-2 activation
Fraser, B. J., Beldar, S., Seitova, A., Hutchinson, A., Mannar, D., Li, Y., Kwon, D., Tan, R., Wilson, R. P., Leopold, K., Subramaniam, S., Halabelian, L., Arrowsmith, C. H., Benard, F.
10.1101/2021.06.23.449282 — Posted: 2021-06-24
Lipid and nucleocapsid N-protein accumulation in COVID-19 patient lung and infected cells
Grootemaat, A., van der Niet, S., Scholl, E. R., Roos, E., Schurink, B., Bugiani, M., Miller, S. E., Larsen, P. W., Pankras, J., Reits, E. E., van der Wel, N. N.
10.1101/2021.06.24.449252 — Posted: 2021-06-24
SARS-CoV-2-Triggered Mast Cell Rapid Degranulation Induces Alveolar Epithelial Inflammation and Lung Injury
Wu, M.-L., Liu, F.-L., Sun, J., Li, X., He, X.-Y., Zheng, H.-Y., Pei, R.-J., Sun, H., Zhou, Y.-H., Yan, Q.-H., Wu, C.-X., Chen, L., Yu, G.-Y., Chang, J., Jin, X., Zhao, J., Chen, X.-W., Zheng, Y.-T., Wang, J.-H.
10.1101/2021.06.24.449680 — Posted: 2021-06-24
The impact of legislation on Covid-19 mortality in a Brazilian federative unit was mediated by social isolation.
Diaz-Quijano, F. A., Ribeiro, T. B., da Rosa, A. V., Reis, R., Aith, F., Ventura, D. F. L.
10.1101/2021.06.16.21259057 — Posted: 2021-06-24
OVARIAN GRANULOSA CELLS FROM WOMEN WITH PCOS EXPRESS LOW LEVELS OF SARS-COV-2 RECEPTORS AND CO-FACTORS
Naigaonkar, A. A., Patil, K. M., Joseph, S., Hinduja, I., Mukherjee, S.
10.1101/2021.06.15.21259003 — Posted: 2021-06-24
The effect of Health Literacy on COVID-19 Vaccine Hesitancy: The Moderating Role of Stress
Zhang, F., Zhang, H., Li, Y., Peng, S., Jiang, Y., Jin, H.
10.1101/2021.06.16.21258808 — Posted: 2021-06-24
Optimal Selection of COVID-19 Vaccination Sites at the Municipal Level
Cabanilla, K. I. M., Enriquez, E. A. T., Mendoza, R., Mendoza, V. M. P.
10.1101/2021.06.20.21259194 — Posted: 2021-06-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).